Imiquimod is a ligand for Toll-like receptor (TLR) 7 and TLR8 and is used in dermatology for the treatment of several cutaneous diseases, including actinic keratosis and basal cell carcinoma, as well as viral diseases such as condyloma accuminatum. Here, TLR8 is linked to basal cell carcinoma.